Journal of Medicinal Chemistry · 1995 · 39 citations · 0 references
MedicineMedicinal ChemistryPharmacologyMolecular PharmacologyNeuropharmacologyStructure-activity RelationshipsDrug ReceptorsDrug-receptor InteractionsLigand BindingReceptor PharmacologyReceptor-ligand InteractionsSerotonergic Pharmacology5-Hydroxytryptamine 1A Receptor Agonists5-Hydroxytryptamine Receptor PharmacologyBuspirone PharmacologyMolecular Structure DeterminationReceptor-ligand SelectivitySerotonin Receptor Pharmacology
An interdisciplinary (X-ray, 1H and 13C NMR, IR, and theoretical quantum mechanical) study on the potent 5-HT1A receptor ligand buspirone (1) and its two structural analogues, mesmar (4,4-dimethyl-1-[4-[4-(2-quinolinyl)-1-piperazinyl]butyl]-2,6- piperidinedione) (2) and kaspar (8-[4-[4-(2-quinolinyl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane - 7,9-dione) (3), has been reported. The results have shown that buspirone-like molecules should appear in an extended rod-shape form, possessing several potential interaction sites with the receptor.